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Proceeding (Extension course 1)
Know the urine and blood tests of chronic kidney disease
Shunji Namba
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Abstract
Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function
over a period of months or years. Early on there are typically no symptoms. Causes of chronic kidney disease
include diabetes, high blood pressure, glomerulonephritis, etc. Complications may include Cardiovascular
disease, high blood pressure, or anemia. Diagnosis is generally by blood tests to measure the creatinine and
urine tests to measure the albumin. Early detection and treatment can often keep chronic kidney disease from
getting worse. When kidney disease progresses, it may eventually lead to kidney failure, which requires
dialysis or a kidney transplant to maintain life. CKD is divided into five stages. The earlier kidney disease is
detected, the better the chance of slowing or stopping its progression. Recent years, a marker for early
detection of renal dysfunction has been developed and used clinically. In this article, we will outline these.
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